Literature DB >> 15898173

Dengue virus type 3, Cuba, 2000-2002.

Rosmari Rodriguez-Roche, Mayling Alvarez, Edward C Holmes, Lidice Bernardo, Gustavo Kouri, Ernest A Gould, Scott Halstead, Maria G Guzman.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15898173      PMCID: PMC3320353          DOI: 10.3201/eid1105.040916

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: In 1994, dengue virus type 3 (DENV-3) was reintroduced into Latin America after an absence of 17 years, and was isolated almost simultaneously in Nicaragua and Panama. In September 2000, DENV-3 was isolated for the first time in Cuba, producing a small outbreak that affected 3 areas of Havana City. In total, 138 cases of dengue fever were confirmed, with either DENV-3 or DENV-4 as the etiologic agents. No dengue hemorrhagic fever cases were observed, and the outbreak was brought under control within 6 weeks (). At the end of June 2001, dengue was again reported in Havana. Through the end of February 2002, a total of 14,443 dengue cases were reported for the entire country, including 81 cases of dengue hemorrhagic fever and 3 fatalities (). To understand the molecular epidemiology of DENV-3 in Cuba, and particularly to determine whether the 2000 and 2001 outbreaks were caused by the same viral genotype, the complete envelope (E) gene sequences of isolates from both outbreaks were determined. To assist in this analysis, we also sequenced a DENV-3 strain representing the 1994 Nicaraguan epidemic, the first one isolated in Latin America in 1994 (). Three DENV-3 viruses isolated during the 2000–2002 Cuban outbreaks were studied. Two were obtained from acute-phase sera and the other from a spleen section sample from a patient who died. Serum samples and macerated spleen fragments were spread onto C6/36 mosquito cells (grown at 33°C) by using the rapid centrifugation assay (). Viral RNA was extracted from 200 μL of supernatant medium of virus-infected cells by using the RNAgents Total RNA Isolation system (Promega, Madison, WI, USA). The E gene was amplified by using reverse transcription–polymerase chain reaction (RT-PCR) as described previously (). Double-stranded sequencing of the E gene was conducted on an ABI sequencer according to the manufacture's protocol (Applied Biosystems, Foster City, CA, USA). All sequences determined in this study have been deposited in GenBank (accession nos. AY702030–AY702033). The E gene sequence of the 3 Cuban DENV-3 isolates and the single strain from Nicaragua isolated in 1994 were aligned with the E gene sequences (1,479 bp in length) of 60 DENV-3 isolates deposited in GenBank, representing the global genetic diversity of DENV-3. Phylogenetic trees were produced with a maximum likelihood method incorporating the GTR+ G+I model of nucleotide substitution, with the general time-reversible (GTR) substitution matrix, the base composition, the gamma (Γ) distribution of among-site rate variation, and the proportion of invariant sites (I) all estimated from the data. To explore the robustness of particular phylogenetic groupings, a bootstrap resampling analysis was undertaken. All analyses were performed with the PAUP* package (). The tree (Figure) showed 5 major groups or genotypes of DENV-3: 1) a Pacific/Asian group (genotype I); 2) an Asian group, containing a large array of viruses sampled from Thailand and Malaysia (genotype II); 3) a Latin American group that includes the Cuban viruses and isolates from Venezuela, Martinique, and Nicaragua, as well as those from Samoa, India, and Sri Lanka (genotype III); 4) a small group of Asian viruses (genotype IV); and 5) a final, most divergent group containing virus samples from Puerto Rico (genotype V). A similar genotype structure of DENV-3 has been observed in previous studies of this virus (,–). The 3 Cuban viruses clearly fall into genotype III.
Figure

Maximum likelihood (ML) phylogenetic tree showing the evolutionary relationships among the E gene sequences of 64 strains of DENV-3. All branch lengths are drawn to scale, and tree was rooted using strains from the Puerto Rico 1960s epidemic, which always appear as the most divergent. Bootstrap support values are shown for key nodes only; the Cuban isolates are designated by bold type. See Table A1 for GenBank accession numbers of the other DENV-3 strains used in this analysis.

Maximum likelihood (ML) phylogenetic tree showing the evolutionary relationships among the E gene sequences of 64 strains of DENV-3. All branch lengths are drawn to scale, and tree was rooted using strains from the Puerto Rico 1960s epidemic, which always appear as the most divergent. Bootstrap support values are shown for key nodes only; the Cuban isolates are designated by bold type. See Table A1 for GenBank accession numbers of the other DENV-3 strains used in this analysis.
Table A1

Dengue virus type 3 (DENV-3) strains used in phylogenetic analysis

DENV-3 strainGenBank accession no.
D3 Brazil/00AY038605
D3 China 80-2/1980AF317645
D3 Fiji/92L11422
D3 India/84L11424
D3 Indonesia/78L11426
D3 Indonesia/85L11428
D3 Malaysia LN5547/92AF147457
D3 Malaysia LN2632/93AF147459
D3 Malaysia/74L11429
D3 Malaysia/81L11427
D3 Malaysia LN5547/92AF147457
D3 Malaysia LN2632/93AF147459
D3 Malaysia LN1746/93AF147458
D3 Malaysia LN6083/94AF147460
D3 Malaysia LN7029/94AY338493
D3 Malaysia LN8180AY338492
D3 Martinique 1243/99AY099337
D3 Martinique 1706/00AY099339
D3 Martinique 2012/01AY099340
D3 Malaysia LN1746/93AF147458
D3 Malaysia/81L11427
D3 Malaysia LN6083/94AF147460
D3 Malaysia/74L11429
D3 Malaysia LN7029/94AY338493
D3 Malaysia LN8180AY338492
D3 Martinique 1243/99AY099337
D3 Martinique 1706/00AY099339
D3 Martinique 2012/01AY099340
D3 Martinique 2023/01AY099341
D3 Martinique 2336/01AY099342
D3 Mexico 6097/95AY146763
D3 Myanmar 31985KLA/98AY145712
D3 Philippines/56L11423
D3 Philippines H87/57M93130
D3 Philippines/83L11432
D3 Puerto Rico/63L11433
D3 Puerto Rico/77AY146761
D3 Samoa/86L11435
D3 Sri Lanka/81L11431
D3 Sri Lanka/85L11436
D3 Sri Lanka/89L11437
Indeed, strain D3.Nicaragua.24/94 falls at the base of the Latin American clade within genotype III, as would be expected if it was the first DENV-3 strain isolated from this region in 1994. Moreover, the most divergent strains from genotype III (with the exception of a single strain from Samoa) come from Asia, which suggests that this group of viruses was exported from Asia to Latin America in the early 1990s. Finally, the Cuban viruses fall into 2 distinct groups: the 116/00 strain, isolated during the 2000 outbreak, is very closely related to the Brazilian/Martinique viruses isolated in the same year, whereas strains 580/01 and 21/02, isolated in 2001–2002, appear to have diverged distinctly to form a separate cluster (99% bootstrap support). A total of 15 nucleotide differences were distributed throughout the E gene. Of these, 12 were synonymous and 3 were nonsynonymous substitutions resulting in amino acid changes (E19 Thr/Pro, E226 Ile/Thr, and E329 Ala/Val). Moreover, 2 different nucleotide substitutions were found for the 2 isolates obtained during the major outbreak (2001–2002). These substitutions resulted in a nonconservative amino acid change (E22 Asp/Val). The ABI chromatograms of these sequences showed populations in this position, but the predominant population for each strain differed. By using appropriate phylogenetic methods, deducing the most likely dispersal pattern for closely related dengue virus strains with different patterns of spatial and temporal sampling is possible. The current study strongly suggests that an Asian DENV-3 virus assigned to genotype III has evolved in situ in the Caribbean region since 1994. The nucleotide differences observed in the Cuban isolates support the hypothesis that DENV-3 was introduced twice into Cuba from the wider Latin American region. Further evidence to support this hypothesis is that during the interepidemic period, from January to June 2001, no immunoglobulin (Ig) M–positive samples from patients with fever and suspected dengue cases were observed, which suggests that the virus was not circulating. Therefore, these data are consistent with the idea that, rather than in situ evolution, a second introduction of the virus occurred in 2001. By comparing the amino acid sequences of the Cuban isolates with other DENV-3 strains assigned to genotype III, we confirmed that several distinct amino acid replacements had occurred. In particular, the nonconservative substitution Ala/Val was seen in the Nicaragua 1994, Mexico 1996, Cuba 2001–2002, and Venezuela 2001–2002 isolates. However, the Cuba 2000, Brazil 2000, and Martinique 1999–2001 isolates preserved the Ala at this position, as was also the case for viruses sampled from the putative Asian source (from India and Sri Lanka). The functional significance of amino acids at this position has not been determined.
  8 in total

Review 1.  Dengue: an update.

Authors:  María G Guzmán; Gustavo Kourí
Journal:  Lancet Infect Dis       Date:  2002-01       Impact factor: 25.071

2.  Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells.

Authors:  R Rodríguez Roche; M Alvarez; M G Guzmán; L Morier; G Kourí
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

3.  Molecular evolution and epidemiology of dengue-3 viruses.

Authors:  R S Lanciotti; J G Lewis; D J Gubler; D W Trent
Journal:  J Gen Virol       Date:  1994-01       Impact factor: 3.891

4.  [Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas].

Authors:  M G Guzmán; S Vázquez; E Martínez; M Alvarez; R Rodríguez; G Kourí; J de los Reyes; F Acevedo
Journal:  Bol Oficina Sanit Panam       Date:  1996-08

5.  Molecular epidemiology of dengue virus type 3 in Venezuela.

Authors:  N Y Uzcategui; G Comach; D Camacho; M Salcedo; M Cabello de Quintana; M Jimenez; G Sierra; R Cuello de Uzcategui; W S James; S Turner; E C Holmes; E A Gould
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

6.  Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period.

Authors:  V Wittke; T E Robb; H M Thu; A Nisalak; S Nimmannitya; S Kalayanrooj; D W Vaughn; T P Endy; E C Holmes; J G Aaskov
Journal:  Virology       Date:  2002-09-15       Impact factor: 3.616

7.  Dengue 3 epidemic, Havana, 2001.

Authors:  Otto Peláez; María G Guzmán; Gustavo Kourí; Raúl Pérez; José L San Martín; Susana Vázquez; Delfina Rosario; Regla Mora; Ibrahim Quintana; Juan Bisset; Reynel Cancio; Ana M Masa; Osvaldo Castro; Daniel González; Luis C Avila; Rosmari Rodríguez; Mayling Alvarez; Jose L Pelegrino; Lídice Bernardo; Irina Prado
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

8.  Emergence and global spread of a dengue serotype 3, subtype III virus.

Authors:  William B Messer; Duane J Gubler; Eva Harris; Kamalanayani Sivananthan; Aravinda M de Silva
Journal:  Emerg Infect Dis       Date:  2003-07       Impact factor: 6.883

  8 in total
  12 in total

Review 1.  The global distribution of yellow fever and dengue.

Authors:  D J Rogers; A J Wilson; S I Hay; A J Graham
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

2.  Prolonged co-circulation of two distinct Dengue virus Type 3 lineages in the hyperendemic area of Medellin, Colombia.

Authors:  Marta C Ospina; Francisco J Diaz; Jorge E Osorio
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

3.  Origin and evolution of dengue virus type 3 in Brazil.

Authors:  Josélio Maria Galvão de Araújo; Gonzalo Bello; Hector Romero; Rita Maria Ribeiro Nogueira
Journal:  PLoS Negl Trop Dis       Date:  2012-09-06

4.  Intra-genotypic variation of predominant genotype II strains of dengue type-3 virus isolated during different epidemics in Thailand from 1973 to 2001.

Authors:  Aimee Zhang; Piyawan Chinnawirotpisan; Yuxin Tang; Yanfei Zhou; Julia Lynch; Stephen Thomas; Siripen Kalayanarooj; Robert Putnak; Chunlin Zhang
Journal:  Virus Genes       Date:  2012-03-13       Impact factor: 2.198

Review 5.  Dengue--quo tu et quo vadis?

Authors:  Rubing Chen; Nikos Vasilakis
Journal:  Viruses       Date:  2011-09-01       Impact factor: 5.048

6.  Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.

Authors:  William B Messer; Boyd Yount; Kari E Hacker; Eric F Donaldson; Jeremy P Huynh; Aravinda M de Silva; Ralph S Baric
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

Review 7.  Understanding the dengue viruses and progress towards their control.

Authors:  Rosmari Rodriguez-Roche; Ernest A Gould
Journal:  Biomed Res Int       Date:  2013-07-09       Impact factor: 3.411

8.  Population structure of the dengue viruses, Aragua, Venezuela, 2006-2007. Insights into dengue evolution under hyperendemic transmission.

Authors:  Rosmari Rodriguez-Roche; Elci Villegas; Shelley Cook; Pauline A W Poh Kim; Yoandri Hinojosa; Delfina Rosario; Iris Villalobos; Herminia Bendezu; Martin L Hibberd; Maria G Guzman
Journal:  Infect Genet Evol       Date:  2011-12-17       Impact factor: 3.342

9.  Molecular epidemiology of dengue virus strains from Finnish travelers.

Authors:  Eili Huhtamo; Nathalie Y Uzcátegui; Heli Siikamäki; Auli Saarinen; Heli Piiparinen; Antti Vaheri; Olli Vapalahti
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

10.  Genetic variation in the 3' untranslated region of dengue virus serotype 3 strains isolated from mosquitoes and humans in Brazil.

Authors:  Márcia Gonçalves de Castro; Fernanda Bruycker de Nogueira; Rita Maria Ribeiro Nogueira; Ricardo Lourenço-de-Oliveira; Flávia Barreto dos Santos
Journal:  Virol J       Date:  2013-01-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.